SAVA
HealthcareCassava Sciences, Inc.
$2.10
+$0.01 (+0.48%)
Jan 5, 2026
Price History (1Y)
Analysis
Cassava Sciences, Inc. is a biotechnology company operating in the healthcare sector, with a market capitalization of $101.45M and 30 employees. The company's industry is categorized as Biotechnology. The financial health of Cassava Sciences, Inc. reveals significant net losses, with a Net Income (TTM) of -$106,031,000 and EBITDA of -$69,296,000. This results in gross margins, operating margins, and profit margins of 0.0%. Returns on Equity and Assets are also negative, at -85.4% and -24.8%, respectively. The company maintains a cash balance of $106.08M, while debt information is not available. Valuation metrics for Cassava Sciences, Inc. include a forward P/E ratio of -1.19, which indicates a significant discount to the market. Price to Book is 1.24, and the EV/EBITDA ratio stands at 0.07. The company's beta is -1.01, indicating a high degree of volatility in its stock price.
This analysis is AI-generated for informational purposes only and should not be considered financial advice. Data may be delayed or inaccurate. Always do your own research and consult a qualified financial advisor before making investment decisions.
About Cassava Sciences, Inc.
Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2 clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's disease. Cassava Sciences, Inc. was formerly known as Pain Therapeutics, Inc. and changed its name to Cassava Sciences, Inc. in March 2019. The company was incorporated in 1998 and is based in Austin, Texas.
Visit website →Key Statistics
- Market Cap
- $101.45M
- P/E Ratio
- N/A
- 52-Week High
- $4.98
- 52-Week Low
- $1.15
- Avg Volume
- 1.52M
- Beta
- -1.01
Company Info
- Industry
- Biotechnology
- Exchange
- NCM
- Country
- United States
- Employees
- 30